Kenth Drott serves as the Senior Director of Global Healthcare & Specialty Gases at Linde PLC, where he leverages over 25 years of extensive international experience in the healthcare sector. His role encompasses a broad spectrum of responsibilities, including global research and development, commercialization, and...
Kenth Drott serves as the Senior Director of Global Healthcare & Specialty Gases at Linde PLC, where he leverages over 25 years of extensive international experience in the healthcare sector. His role encompasses a broad spectrum of responsibilities, including global research and development, commercialization, and business development specifically tailored for the healthcare and specialty gases market segments. Kenth's expertise spans the entire care continuum, from emergency medical services to hospitals, intermediate care, and homecare, making him a pivotal figure in advancing high-complexity care models.
At Linde, Kenth is instrumental in driving innovation and strategic growth initiatives that align with the evolving needs of healthcare providers and patients. He leads key projects focused on enhancing product management and development, ensuring that Linde’s offerings in medical gases and devices meet the highest standards of safety and efficacy. His adeptness in marketing management and pricing strategy enables him to position Linde’s products competitively in a rapidly changing marketplace.
Kenth is also recognized for his exceptional team-building and change management skills, fostering a collaborative environment that encourages creativity and efficiency. His proficiency in Six Sigma methodologies enhances operational excellence, ensuring that projects are executed with precision and quality. As a seasoned professional in international business, Kenth is adept at navigating diverse markets, making him a valuable asset in Linde's mission to deliver innovative healthcare solutions globally. Through his leadership, Linde continues to set benchmarks in the healthcare industry, driving sustainable growth and improving patient outcomes.
